BioForm Medical (BFRM) Reports Q4 Loss of $0.43; Guides FY09 Sales
BioForm Medical, Inc. (Nasdaq: BFRM) reports a Q4 loss of $0.43, versus the analyst estimate of a loss of $0.16 and compared to a loss of $1.20 in the same quarter last year. Revenues for the quarter were $16.7 million, versus the consensus of $15.90 million.
Sees FY09 sales in the range of $74-$78 million, versus the consensus of $74.25 million.
BioForm Medical, Inc., a medical aesthetics company, focuses on developing and commercializing products that are used by physicians to enhance a patient's appearance.
Sees FY09 sales in the range of $74-$78 million, versus the consensus of $74.25 million.
BioForm Medical, Inc., a medical aesthetics company, focuses on developing and commercializing products that are used by physicians to enhance a patient's appearance.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
